These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

842 related articles for article (PubMed ID: 25425285)

  • 1. Plasma, salivary and urinary cortisol levels following physiological and stress doses of hydrocortisone in normal volunteers.
    Jung C; Greco S; Nguyen HH; Ho JT; Lewis JG; Torpy DJ; Inder WJ
    BMC Endocr Disord; 2014 Nov; 14():91. PubMed ID: 25425285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variability in hydrocortisone plasma and saliva pharmacokinetics following intravenous and oral administration to patients with adrenal insufficiency.
    Thomson AH; Devers MC; Wallace AM; Grant D; Campbell K; Freel M; Connell JM
    Clin Endocrinol (Oxf); 2007 Jun; 66(6):789-96. PubMed ID: 17437510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose ACTH (1 microg) salivary test: a potential alternative to the classical blood test.
    Marcus-Perlman Y; Tordjman K; Greenman Y; Limor R; Shenkerman G; Osher E; Stern N
    Clin Endocrinol (Oxf); 2006 Feb; 64(2):215-8. PubMed ID: 16430723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypothalamic pituitary adrenal function during critical illness: limitations of current assessment methods.
    Arafah BM
    J Clin Endocrinol Metab; 2006 Oct; 91(10):3725-45. PubMed ID: 16882746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose distribution in hydrocortisone replacement therapy has a significant influence on urine free cortisol excretion.
    Bliesener N; Steckelbroeck S; Redel L; Klingmüller D
    Exp Clin Endocrinol Diabetes; 2003 Oct; 111(7):443-6. PubMed ID: 14614652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new less-invasive and more informative low-dose ACTH test: salivary steroids in response to intramuscular corticotrophin.
    Contreras LN; Arregger AL; Persi GG; Gonzalez NS; Cardoso EM
    Clin Endocrinol (Oxf); 2004 Dec; 61(6):675-82. PubMed ID: 15579180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salivary cortisol determined by enzyme immunoassay is preferable to serum total cortisol for assessment of dynamic hypothalamic--pituitary--adrenal axis activity.
    Gozansky WS; Lynn JS; Laudenslager ML; Kohrt WM
    Clin Endocrinol (Oxf); 2005 Sep; 63(3):336-41. PubMed ID: 16117823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical utility of alternative, less invasive sampling techniques in the assessment of oral hydrocortisone therapy in children and adolescents with hypopituitarism.
    Maguire AM; Ambler GR; Moore B; Waite K; McLean M; Cowell CT
    Eur J Endocrinol; 2007 Apr; 156(4):471-6. PubMed ID: 17389462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Replacement therapy of oral hydrocortisone in adrenal insufficiency: the influence of gastrointestinal factors.
    Lennernäs H; Skrtic S; Johannsson G
    Expert Opin Drug Metab Toxicol; 2008 Jun; 4(6):749-58. PubMed ID: 18611115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting Cortisol Exposure from Paediatric Hydrocortisone Formulation Using a Semi-Mechanistic Pharmacokinetic Model Established in Healthy Adults.
    Melin J; Parra-Guillen ZP; Hartung N; Huisinga W; Ross RJ; Whitaker MJ; Kloft C
    Clin Pharmacokinet; 2018 Apr; 57(4):515-527. PubMed ID: 28762136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of adrenal function in cirrhotic patients: salivary cortisol should be preferred.
    Galbois A; Rudler M; Massard J; Fulla Y; Bennani A; Bonnefont-Rousselot D; Thibault V; Reignier S; Bourrier A; Poynard T; Thabut D
    J Hepatol; 2010 Jun; 52(6):839-45. PubMed ID: 20385427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Achieving a physiological cortisol profile with once-daily dual-release hydrocortisone: a pharmacokinetic study.
    Johannsson G; Lennernäs H; Marelli C; Rockich K; Skrtic S
    Eur J Endocrinol; 2016 Jul; 175(1):85-93. PubMed ID: 27129362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoid maintenance therapy following adrenalectomy: assessment of dosage and preparation.
    Kehlet H; Binder C; Blichert-Toft M
    Clin Endocrinol (Oxf); 1976 Jan; 5(1):37-41. PubMed ID: 1248157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Saliva and bloodspot cortisol: novel sampling methods to assess hydrocortisone replacement therapy in hypoadrenal patients.
    Wong V; Yan T; Donald A; McLean M
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):131-7. PubMed ID: 15212655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conventional glucocorticoid replacement overtreats adult hypopituitary patients with partial ACTH deficiency.
    Agha A; Liew A; Finucane F; Baker L; O'Kelly P; Tormey W; Thompson CJ
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):688-93. PubMed ID: 15163331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of Adrenal Crisis: Cortisol Responses to Major Stress Compared to Stress Dose Hydrocortisone Delivery.
    Prete A; Taylor AE; Bancos I; Smith DJ; Foster MA; Kohler S; Fazal-Sanderson V; Komninos J; O'Neil DM; Vassiliadi DA; Mowatt CJ; Mihai R; Fallowfield JL; Annane D; Lord JM; Keevil BG; Wass JAH; Karavitaki N; Arlt W
    J Clin Endocrinol Metab; 2020 Jul; 105(7):2262-74. PubMed ID: 32170323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of oral hydrocortisone - Results and implications from a randomized controlled trial.
    Werumeus Buning J; Touw DJ; Brummelman P; Dullaart RPF; van den Berg G; van der Klauw MM; Kamp J; Wolffenbuttel BHR; van Beek AP
    Metabolism; 2017 Jun; 71():7-16. PubMed ID: 28521880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation in absorption and half-life of hydrocortisone influence plasma cortisol concentrations.
    Hindmarsh PC; Charmandari E
    Clin Endocrinol (Oxf); 2015 Apr; 82(4):557-61. PubMed ID: 25369980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of glucocorticoid therapy with salivary cortisol in secondary adrenal insufficiency.
    Ceccato F; Albiger N; Reimondo G; Frigo AC; Ferasin S; Occhi G; Mantero F; Terzolo M; Scaroni C
    Eur J Endocrinol; 2012 Dec; 167(6):769-76. PubMed ID: 23034783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decrease in salivary cortisol levels after glucocorticoid dose reduction in patients with adrenal insufficiency: A prospective proof-of-concept study.
    Ceccato F; Barbot M; Lizzul L; Selmin E; Saller A; Albiger N; Betterle C; Boscaro M; Scaroni C
    Clin Endocrinol (Oxf); 2018 Feb; 88(2):201-208. PubMed ID: 28973827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.